Psycho-Babble Medication | about biological treatments | Framed
This thread | Show all | Post follow-up | Start new thread | List of forums | Search | FAQ

Re: hm: and aglomelatine is ) venlafaxine too » Negcreep

Posted by Marty on September 3, 2008, at 14:24:25

In reply to Re: hm: and aglomelatine is ) venlafaxine too, posted by Negcreep on September 3, 2008, at 9:29:28

> Brilliant news, still hanging on for news from the EMEA on this one. They usually put out a monthly report on their website in the first week of each month....I'm hoping agomelatine is approved :)
---
I knew you'd like that news Neg :)

Since Dr.Kasper(sp?) is an adviser of EMEA and on the approval commitee and since the EMEA concern wasn't about the safety but about the efficacy, I think it's now safe to expect Valdoxan to be approve in the next couple months.
That said I doubt it will be marketed this month or even the next. But I, for one, can wait as now I feel much better waiting for it knowing it WILL BE marketed. Nothing stands in the way of an European release now.

BTW, I find it quite funny that the study has been financed by Servier and that the main investigator, Dr.Kasper, is on the EMEA approval board ! .. Could you imagine that in the US ? Glaxo Smith Kline, in the 90's, financing a trial for Paxil in which the responsible of the trial is on the approval board of the FDA !? .. that would be one HUGE scandal. Well, it seems to be good practice in Europe and that's just flabbergasting.

/\/\arty


Share
Tweet  

Thread

 

Post a new follow-up

Your message only Include above post


Notify the administrators

They will then review this post with the posting guidelines in mind.

To contact them about something other than this post, please use this form instead.

 

Start a new thread

 
Google
dr-bob.org www
Search options and examples
[amazon] for
in

This thread | Show all | Post follow-up | Start new thread | FAQ
Psycho-Babble Medication | Framed

poster:Marty thread:849952
URL: http://www.dr-bob.org/babble/20080903/msgs/850093.html